Advanced tracking technologies, rising surgical volumes, and regulatory compliance pressures accelerate adoption across ...

Chemotherapy costs associated with receipt of the adoption of oncotype DX in early-stage breast cancer within the SEER-Medicare population. This is an ASCO Meeting Abstract from the 2016 Quality Care ...

The global Surgical Instrument Tracking System Market is expected to be worth US$ 255 billion by 2023. According to Future Market Insights (FMI), the surgical instrument tracking system market is ...

FDA has announced it is permitting marketing of the first surgical instrument set that can be assembled and disassembled inside the body during surgery, Ethicon Endo-Surgery’s Percutaneous Surgical ...